H4D France

H4D H4D provides easy and convenient access to a physician through a connected telehealth kiosk, the Consult Station, supported by a best-in-class technology platform. Industry sectors E health Therapeutics Area Cardiology / Vascular Diseases
Dermatology
Infectious Diseases - Vaccines
Nutrition and Weight Loss
Ophthalmology
Otolaryngology (Ear, Nose, Throat)
Pulmonary/Respiratory Diseases
Psychiatry/Psychology
Your innovative solution

The Consult Station

Which problem are you solving ?

Access to care is an increasing challenge throughout the world at a time when chronic diseases, an ageing population and increasing costs challenge current medical organizations. H4D

Target market segments

Corporations, hospitals, retirement communities, rural and remote areas.

Key value proposition

1) Quality and certification for professional medical use, 2) Large functional coverage for primary care uses, 3) Convenient and easy access to a physician, 4) Cost savings.

VINCENT HILLENMEYER
COO 

Hackensack UMC Mountainside Hospital United States

About HackensackUMC Mountainside Focused on medical excellence and community service for more than a century Patient focused, community oriented, conveniently located and equipped with technology that rivals the nation’s most prestigious healthcare systems, HackensackUMC Mountainside offers a comprehensive and growing array of services delivered by caring and highly skilled medical professionals. We’re proud of the therapeutic and administrative upgrades we have made. We’re the convenient, friendly community hospital that delivers the quality care, medical excellence and technology on which you can depend. HackensackUMC Mountainside has been serving Montclair and its surrounding New Jersey communities since 1891. The physicians, nurses and volunteers who are a part of the Mountainside family are also your friends and neighbors. We're your community, your hospital and your team, working hard on your behalf. Continuously moving forward Never content with the status quo, we continue to add services, staff, programs and technology to benefit our patients and our communities. From our state-of-the-art emergency center with its Fast Track program to our holistic mind-body women's program to our comprehensive cancer center and a weight-loss surgery program recognized nationally as a Center of Excellence, HackensackUMC Mountainside is the right choice in the greater Montclair area. In 1891, the beginning of a great tradition Margaret Jane Merewether Power was a preacher’s daughter who came from England to Montclair in 1874 with her husband. One summer day in 1890 she encountered a child who had fallen from a third-story window. Upset that there was no nearby healthcare facility where the child could be helped, she called on other women in her social circle to find a solution – marking the birth of HackensackUMC Mountainside. By 1891, a three-story cottage belonging to widow Eliza Sheridan had been purchased. Dr. John J.H. Love was named the first President of the Medical and Surgical Staff, and HackensackUMC Mountainside officially began its mission of “caring for, curing and nurturing the sick and injured.” Today, 119 years later, HackensackUMC Mountainside is still carrying out that mission. With 365 beds and 820,000 square feet in total, HackensackUMC Mountainside has come a long way. But some things never change. The compassion and commitment to the community felt by Mrs. Power continues to this day. A member of the Montclair Health Systems, LLC On February 1, Montclair Health System, LLC, a joint venture of LHP Hospital Group, Inc. and Hackensack University Medical Center, initiated the state government process required to acquire Mountainside Hospital.

HackensackUMC Mountainside is unique among New Jersey hospitals. While many others are seeking new owners because their futures remain uncertain, one of the nation’s most prestigious hospitals, HackensackUMC and LHP Hospital Group, Inc. one of the nation’s most innovative capital and healthcare management firms are choosing to affiliate with HackensackUMC Mountainside because of its strength and stability.
Mr Joseph Patanella
Assistant Chief Operating Officer  

Halcyon Cabot Partners Ltd United States

Michael S. SEGAL
President 

HarkerBIO United States

HarkerBIO possesses unique capabilities that accelerate the development of new drugs. 

HarkerBIO is located on the growing Buffalo Niagara Medical Campus, a consortium of the region's premier health care, life sciences research, and medical education institutions, all located on 120 acres in downtown Buffalo, New York.

Specialties

biomolecular crystallization

Mr Artem Evdokimov
Chief Scientific Officer 

HARMONIC PHARMA France

THE COMPANY

Finding new uses of safe drugs based on polypharmacology profiling: Armonco® a clinical candidate for lung cancer.

OBJECTIVES FOR THIS EVENT

Harmonic Pharma is looking for a company which would be interested in acquiring the exclusive license of Armonco® in order to perform its clinical development in lung cancer.

TECHNOLOGY AND PRODUCTS

Harmonic Pharma has developed a unique and innovative know-how combining polypharmacology with relevant animal models mimicking human diseases. This expertise has been applied to identify a clinical candidate for lung cancer from existing safe drugs:  Armonco® has been developed to be licensed out for a clinical trial.

KEY ADVANTAGES

New targeted therapy for lung cancer

Armonco® acting in monotherapy and in combination with existing treatments including inhibitor antibodies

Clinical candidate with already well documented safety in man

Cost-effective process and shortening time to market

Consolidated IP including a specific formulation

Ø  Seeking companies interested in discussing common business opportunities in the cancer area

Arnaud Sinan KARABOGA
Arnaud Sinan KARABOGA
CSO 

HEALTHePRACTICES United States

HEALTHePRACTICES (HeP) provides expertise in assisting healthcare practices and technology companies to achieve specific goals toward the delivery of excellent care to their clients. We provide Business Development and Consulting support with a focus on all aspects of telemedicine with a particular interest in medical imaging.

Mr Howard Reis
President 

Healthios United States

HealthiosXchange is the premier online capital market dedicated exclusively to the global healthcare industry. Employing “Crowdfunding” as the cornerstone of a new paradigm in healthcare investing, the H/X offers direct access from "seed" to "exit" to the most promising healthcare companies on a “No Fee No Carry” basis. 

Healthios, the founder of HealthiosXchange, is a boutique investment bank dedicated exclusively to the global healthcare industry: 

- The most compelling growth companies 
- The most dynamic industry sectors 
- The most sophisticated institutional investors 
- The most active strategic buyers and partners 

Healthios seeks to be the premier investment bank serving the global healthcare industry by combining the experience of (52) transactions in 17 countries with unique access to capital, resources and ideas that are the foundation of superior value.

Specialties

Financing, Partnering, Capital Markets, M&A

Ms Jessica Liang
Analyst 

Hemarina SA France

Hemarina Hemarina : A breakthrough in oxygen carriers for human health. Industry sectors Biotech Therapeutics Area Cardiology / Vascular Diseases
CNS-Neurology
Dental and Oral Health
Dermatology
Gastroenterology / Hepatology
Oncology
Ophthalmology
Orthopedics/Orthopedic Surgery
Pulmonary/Respiratory Diseases
Rare Disease
Your innovative solution

Hemarina develops products that constitute a decisive technological breakthrough in regard to current or past developments of hemoglobin-based oxygen carriers (HBOCs).

Which problem are you solving ?

HEMOXYcarrier� = Universal oxygen carrier (Lack of blood worldwide is ~ 100 millions liters per year) - HEMO2Life : Organ & Tissue preservation - HEMHealing : Wound Healing & Repair

Target market segments

1/ Blood Oxygen Transporter, 2/ Organ & Tissue preservation, 3/ /Wound Healing & Repair

Key value proposition

1/ Unique know how from development to production of oxygen carriers 2/ Strong academic network & partnerships 3/ Broad intellectual property covering Hemarina's technology 4/ international publications

Franck Zal
CEO 

Henry Schein United States

Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the S&P 500® and NASDAQ 100® Indexes, Henry Schein employs more than 18,000 Team Schein Members and serves more than one million customers. 
The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 100,000 branded products and Henry Schein private-brand products in stock, as well as more than 150,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services. 
Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 30 countries. The Company's sales reached a record $10.4 billion in 2014, and have grown at a compound annual rate of approximately 16 percent since Henry Schein became a public company in 1995.

For more information, visit the Henry Schein website at www.henryschein.com

Diana P Friedman
‎Vice President, Data and Business Analytics 

Hospital for Special Surgery United States

Best Hospital, Best Results

HSS is nationally ranked #1 in orthopedics, and #3 in rheumatology by U.S.News & World Report (2015-16). HSS has been top-ranked for both orthopedics and rheumatology for the 24 consecutive years.

Because an infection can be a devastating outcome for an orthopedic patient, Hospital for Special Surgery takes infection control extremely seriously and is proud of the recognition received for our significantly low infection rates

HSS and a complement of physicians within each specialty area accepts most major insurance plans. Our Insurance Advisory Service can answer questions regarding your insurance coverage.

Dr Sergei Rudchenko
Director-Scientist